Vir’s Hep B Combinations Could Bring Functional Cure To More Patients
Updated Results Will Be EASL Late Breaker
The goal of reaching functional cure rates of up to 30% in hepatitis B now looks realistic, and Vir and GSK and others are racing to find the best combinations of novel and existing treatment options - new results at EASL this week will show how they are faring.
